Dyne Therapeutics (NASDAQ:DYN) Price Target Raised to $48.00
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its target price hoisted by HC Wainwright from $36.00 to $48.00 in a research note released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ FY2025 earnings at ($1.41) EPS, FY2026 earnings at $0.23 EPS, […]
More Stories
Elementis (OTCMKTS:ELMTY) Hits New 52-Week High – Here’s What Happened
Elementis plc (OTCMKTS:ELMTY – Get Free Report) shares reached a new 52-week high on Monday . The stock traded as...
iShares Short Duration Bond Active ETF (BATS:NEAR) Hits New 1-Year High – What’s Next?
iShares Short Duration Bond Active ETF (BATS:NEAR – Get Free Report) hit a new 52-week high on Monday . The...
Nuveen ESG Large-Cap Growth ETF (BATS:NULG) Reaches New 1-Year High – Should You Buy?
Nuveen ESG Large-Cap Growth ETF (BATS:NULG – Get Free Report) reached a new 52-week high during trading on Monday ....
Scout24 (ETR:G24) Sets New 52-Week High – Here’s Why
Scout24 SE (ETR:G24 – Get Free Report) shares hit a new 52-week high during trading on Monday . The company...
iShares MSCI USA Value Factor ETF (BATS:VLUE) Hits New 12-Month High – Time to Buy?
iShares MSCI USA Value Factor ETF (BATS:VLUE – Get Free Report)’s share price hit a new 52-week high during mid-day...
iShares MSCI Chile ETF (BATS:ECH) Reaches New 12-Month Low – Time to Sell?
iShares MSCI Chile ETF (BATS:ECH – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on...